Applying Updated ADA/EASD Guidelines to a High Risk, Vulnerable Patient with T2D Who Has Not Achieved Target HA1c Levels after Metformin and an SGLT-2 Inhibitor
Registration
Applying Updated ADA/EASD Guidelines to a High Risk, Vulnerable Patient with T2D Who Has Not Achieved Target HA1c Levels after Metformin and an SGLT-2 Inhibitor
Would you like to continue where you left off?
Applying Updated ADA/EASD Guidelines to a High Risk, Vulnerable Patient with T2D Who Has Not Achieved Target HA1c Levels after Metformin and an SGLT-2 Inhibitor
